Skip to main content
UniHealth

Doctor search

Parvathi A Myer, MD

Gastroenterology · New Rochelle

NPI 1508006370

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Montefiore Medical Center · 2,809 clinicians in this group

Looking this up.

Hospitals listed: Montefiore Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Myer’s office at (866) 633-8255 to ask if they take your plan before you enroll.

California Medical Board record

Licence A101001 · Cancelled

Licence status: Cancelled · since 2007 · University of California, San Diego School of Medicine.

License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Montefiore Medical CenterBronx, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montefiore Medical Center, which runs 8 hospitalsHome of Montefiore Einstein Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 65% would definitely recommend it
    Overall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.23 (1.01 to 1.45), Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.96 (4.4 to 7.52) · 3,522 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 0.95 (0.64 to 1.26) · 17,685 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.679, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.584, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.283, Oct 2024 – Sep 2025
See every measure and the patient survey for Montefiore Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 1 better, 7 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Montefiore Medical Center
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.23 (1.01 to 1.45)WorseJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.96 (4.4 to 7.52) · 3,522 casesWorseJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.64 to 1.26) · 17,685 casesWorseJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.679BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.584BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.283BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.7 (0 to 1.48) · 3,839 casesNo differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths173.71 (144.1 to 203.32) · 293 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 71 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7 · 228 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.9 · 235 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths5.2 · 726 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths9.2 · 878 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths7.5 · 1,164 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.4 · 13,803 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.1 (0 to 0.26) · 18,946 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.05 to 0.36) · 20,155 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.42 (0.03 to 2.82) · 1,159 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.47 (1.29 to 3.65) · 3,435 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.77 (5.48 to 16.06) · 1,120 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.47 (3.29 to 9.65) · 1,192 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.92 (0.57 to 3.28) · 744 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths2.8 · 1,424 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.812No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections1.336No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.058No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits17.8 · 722 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.8 · 2,620 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits22 · 255 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-18 · 840 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-6.4 · 886 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 2,180 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.1 (2.8 to 5.7) · 356 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.2 (10.5 to 16.3) · 356 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.2 · 1,427 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.9 · 170 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits22.3 · 973 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.3 (9.3 to 16.2) · 803 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.1) · 627 casesNo differentJan 2024 – Dec 2024

What patients said (4,904 patients answered, 11% of those asked)

Patient survey stars by topic at Montefiore Medical Center
Cleanliness3
Nurse communication2
Doctor communication3
Communication about medicines2
Discharge information2
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at Montefiore Medical Center
Room was "always" clean68%
Nurses "always" communicated well75%
Doctors "always" communicated well78%
Staff "always" explained59%
Yes, staff "did" give patients this information81%
Yes, staff "did" give patients information about help after discharge79%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand72%
Nurses "always" listened carefully72%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital65%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms82%

Original Medicare doctor bills

$14,416

Medicare paid this office $14,416 for 81 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Removal of polyps or growths of large bowel using an endoscope with mechanical snare13$2,963$228
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope20$2,186$109
Short return visit (20+ min)11$637$58

Procedures Medicare counted

Procedure volume Medicare published
Colonoscopy39More than 59% of doctors who do this
Upper gastrointestinal (GI) endoscopy for acid reflux19More than 50% of doctors who do this

Who their Medicare patients are

81 Original Medicare patients in 2024. Average age 72 · Women 54% · Also on Medicaid 63% · Health risk score 2.58. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.

Conditions among them: High blood pressure 75% · Diabetes 64% · Chronic kidney disease 53% · Coronary heart disease 49% · Heart failure 35% · COPD 27% · Depression 27% · Dementia 27% · Atrial fibrillation 22% · Stroke 21% · Cancer 15%.

The office billed $206,349, Medicare allowed $18,055 and paid $14,416; for 123 services of 22 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202481123722.58$206,349$14,416
2023102145743.28$200,232$15,833
202290121732.63$155,062$13,569
2021112168713.12$224,546$20,459
20206098713.83$100,236$9,479
201988122713.34$120,629$13,610
201879119713.59$88,618$11,130
20176999742.38$107,246$8,981
201680132713.19$133,401$13,571
20152793663.40$36,389$8,785

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes23$2,799$122
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope16$1,762$110
Return visit (30+ min)13$1,537$90
Biopsy of large bowel using a flexible endoscope12$1,284$107
Short return visit (20+ min)12$614$51

2022: 5 services

Original Medicare services billed in 2022
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes17$2,193$129
Diagnostic exam of large bowel using a flexible endoscope11$1,696$154
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope14$1,168$83
Return visit (30+ min)12$1,157$89
Short return visit (20+ min)13$777$56

2021: 4 services

Original Medicare services billed in 2021
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes28$3,739$129
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope22$2,792$127
Biopsy of large bowel using a flexible endoscope14$1,582$113
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope13$1,523$117

2019: 4 services

Original Medicare services billed in 2019
Removal of polyps or growths of large bowel using an endoscope with mechanical snare11$2,555$232
Biopsy of large bowel using a flexible endoscope17$1,657$97
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope11$1,354$113
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes11$726$66

2018: 3 services

Original Medicare services billed in 2018
Biopsy of large bowel using a flexible endoscope12$1,798$138
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope13$1,320$102
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes17$1,104$65

2017: 2 services

Original Medicare services billed in 2017
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes13$1,196$92
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$492$35

2016: 2 services

Original Medicare services billed in 2016
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes12$1,500$125
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes14$1,311$94

Medicaid work

$1,088 in 2023

Medicaid paid $1,088 for 12 billed services this clinician did in 2023, up to 12 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2023
1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES12$1,088
Medicaid work by year
202312112$1,088

Drugs they prescribed that Part D paid

$384,063

Pharmacies billed $384,063 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 231) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.

165 generic and 66 brand-name prescriptions · $384,063 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Stelara11$291,814$26,529
Linzess20$16,870$844
Gavilyte-G46$630$14
Famotidine36$418$12
Sucralfate12$279$23
See all 7 drugs
Every Part D drug this clinician prescribed
Stelara11$291,814$26,529
Linzess20$16,870$844
Gavilyte-G46$630$14
Famotidine36$418$12
Sucralfate12$279$23
Omeprazole34$242$7
Peg-3350 and Electrolytes15$203$14

Year by year

Part D prescribing by year
20242311000% (0)29%$384,063
20233011180% (0)16%$346,915
2022275950% (0)25%$330,670
2021214610% (0)24%$236,674
2020166650% (0)16%$15,422
2019269870% (0)19%$11,378
2018281870% (0)4%$10,506
2017213520% (0)6%$5,366
20163601000% (0)11%$9,161
20155630None21%$1,846
2014178680% (0)11%$23,360
201322197None11%$26,204

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 6 drugs

Part D drugs prescribed in 2023
Stelara12$309,491$25,791
Linzess14$18,120$1,294
Gavilyte-G76$1,199$16
Dicyclomine19$1,195$63
Famotidine70$1,173$17
Omeprazole37$636$17

2022: 8 drugs

Part D drugs prescribed in 2022
Stelara12$297,588$24,799
Linzess19$17,805$937
Famotidine83$808$10
Dicyclomine14$736$53
Gavilyte-G39$584$15
Loperamide12$514$43
Peg-3350 and Electrolytes26$401$15
Omeprazole27$188$7

2021: 4 drugs

Part D drugs prescribed in 2021
Linzess16$12,729$796
Famotidine88$1,131$13
Omeprazole17$352$21
Peg-3350 and Electrolytes14$208$15

2020: 4 drugs

Part D drugs prescribed in 2020
Famotidine75$588$8
Gavilyte-G28$344$12
Peg-3350 and Electrolytes14$172$12
Omeprazole12$67$6

2019: 8 drugs

Part D drugs prescribed in 2019
Linzess11$4,981$453
Polyethylene Glycol 335019$1,646$87
Sucralfate14$662$47
Gavilyte-G45$654$15
Ranitidine65$464$7
Omeprazole47$289$6
Peg-3350 and Electrolytes14$203$14
Famotidine20$193$10

2018: 4 drugs

Part D drugs prescribed in 2018
Polyethylene Glycol 335097$7,850$81
Gavilyte-G62$786$13
Ranitidine58$365$6
Omeprazole28$168$6

2017: 4 drugs

Part D drugs prescribed in 2017
Polyethylene Glycol 335080$3,578$45
Gavilyte-G27$356$13
Ranitidine54$269$5
Omeprazole24$153$6

2016: 6 drugs

Part D drugs prescribed in 2016
Polyethylene Glycol 3350122$4,155$34
Gavilyte-G67$1,009$15
Omeprazole49$296$6
Peg 3350-Electrolyte15$206$14
Peg-3350 and Electrolytes12$156$13
Famotidine11$51$5

2014: 4 drugs

Part D drugs prescribed in 2014
Omeprazole61$1,584$26
Pantoprazole24$635$26
Ondansetron Odt11$407$37
Gavilyte-C22$386$18

2013: 5 drugs

Part D drugs prescribed in 2013
Omeprazole84$2,248$27
Gavilyte-C39$699$18
Ondansetron Odt15$578$39
Pantoprazole16$368$23
Famotidine11$87$8

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
100.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1508006370
Licence
CA A101001California A101001: Cancelled
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr # S101, Stanford, CA, 94305
NPI first listed
2009-03-05
NPI last updated
2009-03-05

This is when the NPI record was last certified, not a medical board exam.